Vietnam Set To Produce 20 Million Doses Of Tamiflu Generic
This article was originally published in PharmAsia News
Executive Summary
Vietnam has decided to produce its own generic of Roche's Tamiflu (oseltamivir) to use in fighting the spreading H1N1 flu virus, if necessary. The minister of health said the country has 880,000 doses of the drug already, but also has the ingredients to make 20 million doses as needed. The Drug Administration of Vietnam is holding back 10 million tablets that have not been completed and has asked local drug makers to stock Tamiflu and be prepared to order imports of the drug if local demand rises. (Click here for more
You may also be interested in...
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.